Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT
Status:
Completed
Trial end date:
2021-01-29
Target enrollment:
Participant gender:
Summary
This study aims to compare safety and efficacy in an exploratory manner between a Tegoprazan
triple therapy and a RAPAE01 triple therapy in H. pylori positive patients.